Patient perceptions of cardiovascular risk, lipid management and statins in type 1 diabetes

被引:1
|
作者
Lan, Nick S. R. [1 ,3 ,7 ]
Hong, Regina S. Y. [1 ,2 ]
Ryan, Christopher [4 ]
Jenkins, Alicia J. [5 ,6 ]
Fegan, P. Gerry [1 ]
机构
[1] Fiona Stanley Hosp, Dept Endocrinol & Diabet, Murdoch, WA, Australia
[2] Fiona Stanley Hosp, Dept Cardiol, Murdoch, WA, Australia
[3] Univ Western Australia, Med Sch, Crawley, WA, Australia
[4] Univ Melbourne, Dept Med, Melbourne, Vic, Australia
[5] Baker IDI Heart & Diabet Inst, Melbourne, Australia
[6] Curtin Univ, Med Sch, Perth, WA, Australia
[7] Fiona Stanley Hosp, Dept Endocrinol & Diabet, 11 Robin Warren Dr, Murdoch, WA 6150, Australia
关键词
Diabetes mellitus type 1; Cardiovascular diseases; Dyslipidaemias; Statins; Risk factors; ADULTS;
D O I
10.1016/j.pcd.2023.07.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Lipid-lowering reduces cardiovascular risk in type 1 diabetes (T1D), but dyslipidaemia remains under-recognised and under-treated. Through patient surveys, barriers to lipid management in T1D were identified, including lack of awareness of cardiovascular risk and cholesterol levels, preference for managing glycaemia over lipids, preference for lifestyle modification over pharmacotherapy, and statin side-effect concerns.
引用
收藏
页码:526 / 528
页数:3
相关论文
共 50 条
  • [31] Carotid ultrasonography as a strategy to optimise the management of cardiovascular risk in patients with type 1 diabetes
    Boswell, L.
    Amor, A. J.
    Vinals, C.
    Ruiz, S.
    Pane, A.
    Blanco, J.
    Vinagre, I.
    Gimenez, M.
    Esmatjes, E.
    Conget, I.
    Ortega, E.
    DIABETOLOGIA, 2019, 62 : S520 - S521
  • [32] Navigating Cardiovascular Risk in Type 1 Diabetes: A Comprehensive Review of Strategies for Prevention and Management
    Maqusood, Shafaque
    Chakole, Vivek
    Dash, Sambit
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (05)
  • [33] Trials of cardiovascular risk factor management in type 2 diabetes
    Patel, Anushka
    Joshi, Rohina
    de Galan, Bastiaan
    CURRENT OPINION IN CARDIOLOGY, 2009, 24 (04) : 288 - 294
  • [34] Dietary management of cardiovascular risk including type 2 diabetes
    Nestel, Paul J.
    Sullivan, David R.
    Mori, Trevor A.
    CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2021, 28 (02) : 134 - 141
  • [35] CARDIOVASCULAR RISK MANAGEMENT IN HYPERTENSIVE TYPE II DIABETES PATIENTS
    Barabanschikova, M. M.
    Pak, L. S.
    JOURNAL OF HYPERTENSION, 2009, 27 : S397 - S397
  • [36] Cardiovascular disease risk prediction in type 1 diabetes
    Farran, B.
    McGurnaghan, S.
    Blackbourn, L.
    McKeigue, P. M.
    Colhoun, H. M.
    DIABETOLOGIA, 2017, 60 : S532 - S533
  • [37] Risk Factors for Cardiovascular Disease in Type 1 Diabetes
    Nathan, David M.
    Bebu, Ionut
    Braffett, Barbara H.
    Lachin, John M.
    Orchard, Trevor J.
    Cowie, Catherine C.
    Lopes-Virella, Maria
    Schutta, Mark
    DIABETES, 2016, 65 (05) : 1370 - 1379
  • [38] Cardiovascular risk perceptibn in patients with type 1 diabetes
    Hansen, MM
    Young, DA
    Hoff, HK
    Liu, HP
    DIABETES, 2004, 53 : A223 - A224
  • [39] Menopause and Cardiovascular Risk in Women with Type 1 Diabetes
    Keshawarz, Amena
    Duca, Lindsey M.
    Shah, Viral N.
    Pyle, Laura
    Sippl, Rachel M.
    Snell-Bergeon, Janet K.
    DIABETES, 2016, 65 : A122 - A122
  • [40] Cardiovascular disease risk in type 1 diabetes Reply
    Huxley, Rachel R.
    Peters, Sanne A. E.
    Mishra, Gita D.
    Woodward, Mark
    Lancet Diabetes & Endocrinology, 2015, 3 (05): : 317 - 317